Move follows fears over jobs and control when private equity firm CD&R entered talks to buy Opella for €16bn
The French government is to take a stake in the pharmaceutical company Sanofi’s consumer healthcare division to try to quell a backlash as the US private equity firm Clayton, Dubilier & Rice enters talks to buy the unit for €16bn (£13.3bn).
Sanofi is spinning off Opella, which makes the paracetamol brand Doliprane, the laxative Dulcolax and other over-the-counter medicines. However, the revelation of talks with CD&R earlier this month prompted concerns over French jobs and the loss of control to a foreign company.
More Stories
Putin calls for alternative international payment system at Brics summit
Project to build German EV microchip factory put on hold
Several killed in terrorist attack at Turkish aerospace company, says minister